-
Mashup Score: 29Lonsurf and Talzenna for Cancers with TP53 Mutations - 13 hour(s) ago
The combination of Lonsurf and talazoparib (Talzenna) selectively killed cancer cells with mutations in the TP53 gene, researchers found in a study in mice.
Source: www.cancer.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Grants & Training - 7 day(s) ago
Information about grants and other funding opportunities for cancer research, the NCI grants process, and funding for training.
Source: www.cancer.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 6
Study identifies gene changes that increase prostate cancer mortality rate for Puerto Rican men
Source: endeavor.moffitt.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 13
Investigators study safety and efficacy of mRNA-based cancer vaccine combined with immunotherapy
Source: endeavor.moffitt.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Shop Talk : Oncology Times - 20 day(s) ago
An abstract is unavailable.
Source: journals.lww.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 525 years of Cancer Research and Care on the Island of Ireland - 20 day(s) ago
The Ireland-Northern Ireland-National Cancer Institute Cancer Consortium celebrates its 25th Annivesary
Source: www.cancer.govCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 35Teacher-student collaborated multiple instance learning for pan-cancer PDL1 expression prediction from histopathology slides - 23 day(s) ago
Nature Communications – PDL1 expression is a common biomarker for immunotherapy response in cancer, and it is usually quantified using immunohistochemistry. Here, the authors develop a weakly…
Source: www.nature.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 3Trans Dudes with Lady Cancer - 26 day(s) ago
A documentary film where the title says it all, except… They are housemates and were diagnosed in the same month.
Source: www.transdudeswithladycancer.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 9
The study evaluated all categories of cancer studies, such as treatment trials, biorepository studies and quality of life studies—the first time an estimate of participation in all types of cancer studies has been reported. Moreover, enrollment in cancer treatment trials was 7.1%, a notably higher participation rate than previous estimates of 2%-3%. The study also found that enrollment in treatment trials was over five-fold higher at National Cancer Institute-designated cancer centers than at community
Source: www.fredhutch.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8
The study evaluated all categories of cancer studies, such as treatment trials, biorepository studies and quality of life studies—the first time an estimate of participation in all types of cancer studies has been reported. Moreover, enrollment in cancer treatment trials was 7.1%, a notably higher participation rate than previous estimates of 2%-3%. The study also found that enrollment in treatment trials was over five-fold higher at National Cancer Institute-designated cancer centers than at community
Source: www.fredhutch.orgCategories: General Medicine News, Onc News and JournalsTweet
Researchers have identified a drug combination that selectively kills cancer cells with mutations in the TP53 gene. Such mutations are found in more than half of all cancers, including most colorectal and pancreatic cancers. https://t.co/XaHxYEniKK #CancerResearch